Welcome Remarks by Official from Nanjing Municipal People’s Government
08:40 - 08:45
主办方致辞
Welcome Remarks by the Hosts
张抒扬, 中国医药创新促进会会长，北京协和医院院长
ZHANG Shuyang, Chairman of PhIRDA, President of Peking Union Medical College Hospital
08:45 - 10:00
第二阶段：主旨报告
Session II: Keynote Speech
主持人 Moderator
李佳, 中国医药创新促进会副会长，中国科学院上海药物研究所所长
LI Jia, Vice President of PhIRDA,
Director of Shanghai Institute of Materia Medica, Chinese Academy of Sciences
戴洪斌, 中国医药创新促进会副会长，恒瑞医药副董事长
DAI Hongbin, Vice President of PhIRDA,
Vice Chairman of Jiangsu Hengrui Pharmaceuticals Co., Ltd.
08:45 - 09:10
主旨报告1
Keynote Speech 1
原创新药研发中国药大布局
China Pharmaceutical University's Arrangements and Reflections on R&D of First-in-Class Drugs
郝海平, 中国药科大学校长
HAO Haiping, President of China Pharmaceutical University
09:10 - 09:35
主旨报告2
Keynote Speech 2
中国医药创新迈向新兴支柱产业的思考
Reflections on China's Pharmaceutical Innovation Advancing into an Emerging Pillar Industry
宋瑞霖, 中国医药创新促进会首席专家
SONG Ruilin, Chief Expert of PhIRDA
09:35 - 10:00
主旨报告3
Keynote Speech 3
以金融助力创新药全球领航——聚势汇能，探索产融协同发展之路
Support Global Leadership of China’s Innovative Drug Industry Through Finance: Mobilize Resources to Explore the Path for Industry-Finance Integrated Development
李稳狮, 中国民生银行副行长
LI Wenshi, Executive Vice President of China Minsheng Bank
10:05 - 12:00
第三阶段：主题讨论
Session III: Panel Discussion
10:05 - 11:00
主题讨论1
Panel 1
聚势向新——中国创新药的原始创新、价值兑现与全球竞争
Converge to Innovate: Original Innovation, Value Realization and Global Competition of China’s Innovative Drugs
主持人 Moderator
杨大俊, 亚盛医药董事长兼首席执行官
YANG Dajun, Chairman of the Board and CEO, Ascentage Pharma
讨论嘉宾： Panelist:
蒋建东, 中国工程院院士，中国医学科学院北京协和医学院药学院院长
JIANG Jiandong, Academician of Chinese Academy of Engineering,
Dean of School of Pharmaceutical Sciences,
Chinese Academy of Medical Sciences and Peking Union Medical College
陈启宇, 复星国际执行董事兼联席首席执行官
CHEN Qiyu, Executive Director and Co-CEO, Fosun International
丁列明, 中国医药创新促进会副会长，贝达药业董事长兼首席执行官
DING Lieming, Vice President of PhIRDA,
Chairman of the Board and CEO of Betta Pharmaceutical Co., Ltd.
任晋生, 中国医药创新促进会副会长，先声药业集团董事长兼首席执行官
REN Jinsheng, Vice President of PhIRDA,
Chairman and CEO, Simcere Pharmaceutical Group Limited
单国洪, 中国医药创新促进会副会长，百济神州高级副总裁，大中华区、中亚及南亚区总经理
Sean SHAN, Vice President of PhIRDA,
Senior Vice President and General Manager of Greater China, Central & South Asia, BeOne Medicines
梁锦, 中金公司董事总经理、投行委委员
LIANG Jin, Member of the Management Committee of the Investment Banking Department, CICC
柳丹, Pivotal bioVenture中国区（碧沃投资本）管理合伙人
Dan LIU, Managing Partner of Pivotal bioVenture China
11:05 - 12:00
主题讨论2
Panel 2
智药启新——AI医药的技术突破、生态共建与产业落地
AI-empowered Pharma Innovation: Technological Breakthroughs, Ecosystem Co-Creation and Industrial Deployment
主持人 Moderator
许小林, 华盖资本创始合伙人
XU Xiaolin, Founding Partner and Chairman of Huagai Capital
讨论嘉宾： Panelist:
李佳, 中国医药创新促进会副会长，中国科学院上海药物研究所所长
LI Jia, Vice President of PhIRDA,
Director of Shanghai Institute of Materia Medica, Chinese Academy of Sciences
樊杰, 华为制药军团总裁
FAN Jie, President of Pharmaceutical BU, Huawei Technologies Co., Ltd.
任峰, 英矽智能联席首席执行官兼首席科学官
REN Feng, Co-CEO and Chief Scientific Officer at Insilico Medicine
吴以芳, 康桥资本执行运营合伙人，云顶新耀董事会主席
Bill WU, Executive Operating Partner of CBC Group, Chairman of Everest Medicines
刘维, 百图生科联合创始人兼首席执行官
LIU Wei, Co-Founder & CEO of BioMap
张书明, 香港交易所董事总经理兼亚洲区上市发行服务部主管
Kelvin TEO, Managing Director, Head of Asia Issuer Services, HKEX
会议咨询